RareSearch

8.7

Excellent

376 reviews

Communication: 8.8

Timeliness: 8.9

Accuracy: 7.6

Staff: 8.8

Value: 8.9

Tabitha McLaughlin IV

🇮🇩 Indonesia

8.6

Reviewed: October 2, 2023

- Patient Engagement
- 8 weeks August - September 2023
- Clinical Research Organization

Impressive patient engagement strategies, significant improvement in recruitment rates.

The patient engagement strategies implemented were impressive and led to a significant improvement in our recruitment rates. The team's experience in patient-centered approaches was evident and made a real difference.

Elizabeth Boehm IV

🇫🇷 France

8.7

Reviewed: May 22, 2023

- Patient Recruitment
- 8 weeks March - April 2023
- Clinical Research Organization

Highly effective patient recruitment strategies, project completed on time.

The patient recruitment strategies were highly effective, and the project was completed within the agreed timeframe. The team was very professional, and their expertise in patient engagement was evident throughout.

Peter Hilpert DVM

🇰🇷 South Korea

9.1

Reviewed: April 6, 2024

- HTA Submission
- 8 weeks February - March 2024
- Biotech Company

Comprehensive and well-executed HTA submission.

The HTA submission was comprehensive and well-executed. The team managed the complexities of the submission process expertly, ensuring that all necessary data was included and well-presented.

Jorge DuBuque

🇰🇷 South Korea

9.3

Reviewed: September 14, 2023

- Project Management
- 10 weeks July - September 2023
- Biotech Company

Seamless project management, results exceeded expectations.

Project management was seamless, and the team exceeded our expectations. They handled all aspects of the project with professionalism and efficiency, keeping us informed every step of the way.

Robyn Hackett

🇺🇸 United States

8.9

Reviewed: July 3, 2024

- Stability Studies
- 18 months January 2023 - June 2024
- Pharmaceutical Company

Accurate and reliable stability studies, clear reporting.

The stability studies were conducted with precision, and the reporting was clear and thorough. The results provided us with the necessary data to proceed with our regulatory submissions confidently.

Archie Waelchi

🇧🇷 Brazil

9.3

Reviewed: March 12, 2024

- Market Access Strategy
- 6 weeks January - February 2024
- Pharmaceutical Company

Strategic market access analysis, insightful recommendations.

The market access analysis provided strategic insights that were crucial to our launch strategy. The team's recommendations were data-driven and actionable, helping us to make informed decisions.